Fukuda Denshi Co., Ltd. Provides Earnings Guidance for the Year Ending March 31, 2021
July 30, 2020
Share
Fukuda Denshi Co., Ltd. provided earnings guidance for the year ending March 31, 2021. For the year ending March 31, 2021, the company expects net sales of ¥132,000 million, operating profit of ¥12,800 million, profit attributable to owners of parent of ¥9,100 million or ¥601.88 per share.
FUKUDA DENSHI CO., LTD. is a Japan-based company mainly engaged in manufacture, purchase and sale of medical electronic equipment. The Company operates in four business segments. The Biopsy Device segment mainly involves in the manufacture, trading and sales of electrocardiographs, ultrasound diagnostic imaging equipment, automated hemocytometers, etc. The Biological Information Monitoring segment involves in the manufacture, trading and sale of biological information monitors. The Therapy Apparatus segment involves in the manufacture, trading and sale of defibrillators, ventilators, pacemakers, catheters, home rental business, etc. The Consumable Supplies and Others segment provides the consumable goods of equipment for all segments as well as repair and maintenance services.
FUKUDA DENSHI CO., LTD. 
